Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Capadenoson in Persistent or Permanent Atrial Fibrillation
NCT00568945Phase 2Completed
- Sponsor
- Bayer
- Start
- Jan 2008
- Primary completion
- Nov 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of capadenoson in Atrial fibrillation (AFib), sponsored by Bayer. Started Jan 2008; status: completed.
02
Drugs
capadenoson
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT00568945.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00568945.